Pronađeno: 1-5 / 5 radova

Autori: Margolin David

>> Filter: Samo Article i Review

Naslov Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study (Meeting Abstract)
Autori Arnold Douglas L  Brinar Vesna  Cohen Jeffrey  Coles Alasdair  Confavreux Christian  Fisher Elizabeth  Fox Edward  Giovannoni Gavin  Hartung Hans  Havrdova Eva  Selmaj Krzysztof  Weiner Howard  Stojanovic Miroslav  Lake Stephen  Margolin David  Panzara Michael  Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract)
Autori Havrdova Eva  Arnold Douglas L  Cohen Jeffrey  Coles Alasdair  Confavreux Christian  Fox Edward  Hartung Hans  Selmaj Krzysztof  Weiner Howard  Brinar Vesna  Giovannoni Gavin  Stojanovic Miroslav  Lake Stephen  Margolin David  Oyuela Pedro  Panzara Michael  Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract)
Autori Selmaj Krzysztof  Arnold Douglas L  Brinar Vesna  Cohen Jeffrey  Coles Alasdair  Confavreux Christian  Fox Edward  Giovannoni Gavin  Hartung Hans  Havrdova Eva  Stojanovic Miroslav  Weiner Howard  Lake Stephen  Margolin David  Oyuela Pedro  Panzara Michael  Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints (Meeting Abstract)
Autori Fox Edward  Arnold Douglas L  Brinar Vesna  Cohen Jeffrey  Coles Alasdair  Confavreux Christian  Giovannoni Gavin  Hartung Hans  Havrdova Eva  Selmaj Krzysztof  Stojanovic Miroslav  Weiner Howard  Lake Stephen  Margolin David  Panzara Michael  Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients (Meeting Abstract)
Autori Coles Alasdair  Brinar Vesna  Arnold Douglas L  Cohen Jeffrey  Confavreux Christian  Fox Edward  Hartung Hans  Havrdova Eva  Selmaj Krzysztof  Weiner Howard  Giovannoni Gavin  Stojanovic Miroslav  Lake Stephen  Margolin David  Panzara Michael  Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX